1. Bruce-Chwatt. Man against malaria: conquest or defeat. (1979): Trans. R. Soc. Trop. Med. Hyg., 73, 605–617.
2. Harinasuta T., Bunnag D., Wernsdorfer W. (1983): A phase II clinical trial of mefloquine in patients with chloroquine resistant falciparum malaria in Thailand. Bull. WHO, 61, 299–305.
3. Marchall H. (1986): Chemotherapy of malaria and toxicity of the antimalarial drugs. In: Clinical Malariology, SEAMIC Tokyo, Japan. pp. 320–347.
4. Merkli B., Richle R.W. (1980): Studies on the resistance to single and combined antimalarials in thePlasmodium berghei mouse model. Acta Tropica, 37, 228–231.
5. De Souza J.M., Sheth U.K., De Oliveria R.M.G., Gomes A.T., Cavacante E.Q. (1985). A phase I clinical trial of fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects. Bulletin of World Health Organization. WHO, 63, 611–615.